Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Maloteaux, JM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 53 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Emilien, G; Durlach, C; Aveaux, D; Maloteaux, JM
      Dopamine D-3 agonists

      EXPERT OPINION ON THERAPEUTIC PATENTS
    2. Robinet, EA; Geurts, M; Maloteaux, JM; Pauwels, PJ
      Chronic treatment with certain antipsychotic drugs preserves upregulation of regulator of G-protein signalling 2 mRNA in rat striatum as opposed to c-fos mRNA

      NEUROSCIENCE LETTERS
    3. Emilien, G; Misteli, C; Aveaux, D; Maloteaux, JM
      Life after sequencing

      TRENDS IN BIOTECHNOLOGY
    4. Page, G; Peeters, M; Najimi, M; Maloteaux, JM; Hermans, E
      Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes

      JOURNAL OF NEUROCHEMISTRY
    5. Emilien, G; Ponchon, M; Caldas, C; Isacson, O; Maloteaux, JM
      Impact of genomics on drug discovery and clinical medicine

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    6. Emilien, G; van Meurs, W; Maloteaux, JM
      The dose-response relationship in Phase I clinical trials and beyond: use,meaning, and assessment

      PHARMACOLOGY & THERAPEUTICS
    7. Emilien, G; Maloteaux, JM; Penasse, C; Goodeve, A; Casimir, C
      Haemophilias: advances towards genetic engineering replacement therapy

      CLINICAL AND LABORATORY HAEMATOLOGY
    8. Noel, F; Geurts, M; Maloteaux, JM
      Selective destruction of nigrostriatal dopaminergic neurons does not alter[H-3]-ryanodine binding in rat striatum

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    9. Page, G; Peeters, M; Maloteaux, JM; Hermans, E
      Increased dopamine uptake in striatal synaptosomes after treatment of ratswith amantadine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    10. Emilien, G; Beyreuther, K; Masters, CL; Maloteaux, JM
      Prospects for pharmacological intervention in Alzheimer disease

      ARCHIVES OF NEUROLOGY
    11. Emilien, G; Maloteaux, JM; Beyreuther, K; Masters, CL
      Alzheimer disease - Mouse models pave the way for therapeutic opportunities

      ARCHIVES OF NEUROLOGY
    12. Emilien, G; Maloteaux, JM
      Circadian system and sleep anomaly in depression

      IRISH JOURNAL OF PSYCHOLOGICAL MEDICINE
    13. Emilien, G; Maloteaux, JM; Geurts, M; Hoogenberg, K; Cragg, S
      Dopamine receptors - physiological understanding to therapeutic intervention potential

      PHARMACOLOGY & THERAPEUTICS
    14. Emilien, G; Maloteaux, JM; Ponchon, M
      Pharmacological management of diabetes: Recent progress and future perspective in daily drug treatment

      PHARMACOLOGY & THERAPEUTICS
    15. Geurts, M; Hermans, E; Maloteaux, JM
      Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [S-35]GTP gamma S binding

      LIFE SCIENCES
    16. Geurts, M; Hermans, E; Maloteaux, JM
      Enhanced striatal dopamine D-2 receptor-induced [S-35]GTP gamma S binding after haloperidol treatment

      EUROPEAN JOURNAL OF PHARMACOLOGY
    17. Geurts, M; Hermans, E; Cumps, J; Maloteaux, JM
      Dopamine receptor-modulated [S-35]GTP gamma S binding in striatum of 6-hydroxydopamine-lesioned rats

      BRAIN RESEARCH
    18. Hantson, P; Leonard, F; Maloteaux, JM; Mahieu, P
      How epileptogenic are the recent antibiotics?

      ACTA CLINICA BELGICA
    19. EMILIEN G; MALOTEAUX JM
      PHARMACOLOGICAL MANAGEMENT OF EPILEPSY - MECHANISM OF ACTION, PHARMACOKINETIC DRUG-INTERACTIONS, AND NEW DRUG DISCOVERY POSSIBILITIES

      International journal of clinical pharmacology and therapeutics
    20. EMILIEN G; MALOTEAUX JM; SEGHERS A; CHARLES G
      USE OF A PLACEBO IN CLINICAL-TRIALS

      European psychiatry
    21. HERMANS E; MALOTEAUX JM
      MECHANISMS OF REGULATION OF NEUROTENSIN RECEPTORS

      Pharmacology & therapeutics (Oxford)
    22. EMILIEN G; MALOTEAUX JM
      CURRENT THERAPEUTIC USES AND POTENTIAL OF BETA-ADRENOCEPTOR AGONISTS AND ANTAGONISTS

      European Journal of Clinical Pharmacology
    23. GEURTS M; HERMANS E; MALOTEAUX JM
      DOPAMINE RECEPTOR-MODULATED [S-35] GTP-GAMMA-S BINDING IN STRIATUM OF6-HYDROXYDOPAMINE-LESIONED RATS

      Naunyn-Schmiedeberg's archives of pharmacology
    24. HERMANS E; GEURTS M; MALOTEAUX JM
      CHARACTERIZATION OF THE FUNCTIONAL COUPLING OF THE NEUROTENSIN AND MUSCARINIC RECEPTORS USING AGONISTS-INDUCED [S-35] GTP-GAMMA-S BINDING ASSAY

      Acta neurologica belgica
    25. HERMANS E; VANISBERG MA; GEURTS M; MALOTEAUX JM
      DOWN-REGULATION OF NEUROTENSIN RECEPTORS AFTER LIGAND-INDUCED INTERNALIZATION IN RAT PRIMARY CULTURED NEURONS

      Neurochemistry international
    26. HERMANS E; GEURTS M; MALOTEAUX JM
      AGONIST AND ANTAGONIST MODULATION OF [S-35] GTP-GAMMA-S BINDING IN TRANSFECTED CHO CELLS EXPRESSING THE NEUROTENSIN RECEPTOR

      British Journal of Pharmacology
    27. JEANJEAN AP; LATERRE EC; MALOTEAUX JM
      NEUROLEPTIC BINDING TO SIGMA-RECEPTORS - POSSIBLE INVOLVEMENT IN NEUROLEPTIC-INDUCED ACUTE DYSTONIA

      Biological psychiatry
    28. EMILIEN G; MALOTEAUX JM; SEGHERS A; CHARLES G
      LITHIUM COMPARED TO VALPROIC ACID AND CARBAMAZEPINE IN THE TREATMENT OF MANIA - A STATISTICAL METAANALYSIS

      European neuropsychopharmacology
    29. EMILIEN G; MALOTEAUX JM
      LITHIUM NEUROTOXICITY AT LOW THERAPEUTIC DOSES HYPOTHESES FOR CAUSES AND MECHANISM OF ACTION FOLLOWING A RETROSPECTIVE ANALYSIS OF PUBLISHED CASE-REPORTS

      Acta neurologica belgica
    30. LACOMBLEZ L; BENSIMON G; LEIGH PN; GUILLET P; POWE L; DURRLEMAN S; DELUMEAU JC; MEININGER V; PUECH AJ; WHITEHEAD J; ASSELAIN B; CESARO P; LARREY D; ROSSOR M; ZIMMERMAN HJ; SALZMAN P; DOPPLER V; LLOYD CM; MALOTEAUX JM; DELWAIDE C; LATERRE EC; BOUCHARD JP; DUQUETTE P; GIRARD M; MASSE C; EISEN A; BLIN O; AZULAY JP; BILLETURC F; POUGET J; BOUCHE P; CAMU M; CARLANDER B; BILLIARD M; CLANET M; ANGIBAUD G; ARNEBES MC; BENAZET M; COURATIER P; VALLAT JM; DESNUELLE C; LAGUENY A; ELLIE E; DIB M; ROZIER A; SALACHAS F; VIADER F; DELAUNAY D; DENGLER R; KUTHER G; TROGER M; LUDOLPH A; BACHUS R; GERICKE C; PRZUNTEK H; LANGKAFEL M; SCHIMRIGK K; JOST WH; OSTERHAGE J; PRUDLO J; MORA J; CHAVERRI D; SAENZ E; JEFFERSON D; ORPE V; LANE RJM; ORRELL RW; BARBIE T; MITCHELL JD; KILSHAW J; PALL HS; GOODWIN M; SCHADY W; DUNCAN S; MOORE C; RICHARDS C; SHAW PJ; CHARI G; PICKERING B; SWASH M; HARATI Y; GOOCH CL; ECHOLS CW; MILLER RG; GELINAS DF; QUIEN A; MUNSTAT TL; THORNELL B; ROTHSTEIN JD; CLAWSON L; SUFIT R; CASEY P; DELUMEAU J; TRUFFINET P; DEBOVE C; ENFRIN P; HAMPTON G; MULLER F; NGUYEN T; ROTHFUSS D; SENECHAL A; SHU C; LESWELL P; WHITWORTH P; DEBOE M; DEBRUYCKERE M; FISHER W; KONIG M; VERDUGO L; DELOSTERREROS MS; DEAKIN D; GIGUERE M; ADAIR K; FRANCO M; SKARINSKY D; WEXLER M; PIZZATO M; LEDOUX L; CAMPAGNES E; HARTNETT M; BASTIEN P; BEJUIT R; KIM Y; LELANN L; LEROY F; PAPILLON C; ORVOENFRIJA E
      A CONFIRMATORY DOSE-RANGING STUDY OF RILUZOLE IN ALS

      Neurology
    31. MILLER RG; BOUCHARD JP; DUQUETTE P; EISEN A; GELINAS DF; HARATI Y; MUNSAT TL; POWE L; ROTHSTEIN J; SALZMAN P; SUFIT RL; GUILLET P; BENSIMON G; DELUMEAU JC; DURRLEMAN S; LACOMBLEZ L; LEIGH PN; MEININGER V; MALOTEAUX JM; DELWAIDE C; GIRARD M; MASSE C; BLIN O; AZULAY JP; BILLETURC F; POUGET J; BOUCHE P; CAMU W; CARLANDER B; CLANET M; ANGIBAUD G; ARNEBES MC; BENAZET M; COURATIER P; DESNUELLE C; LAGUENY A; ELLIE E; DIB M; ROZIER A; SALACHAS F; VIADER F; DELAUNAY D; DENGLER R; GUTHER G; TROGER M; LUDOLPH A; BACHUS R; GERICKE C; PRZUNTEK H; LANGKAFEL M; SCHIMRIGK K; JOST WH; OSTERHAGE J; PRUDLO J; MORA J; CHAVERRI D; SAENZ E; JEFFERSON D; ORPE V; LANE RJM; ORRELL RW; LLOYD CM; BARBIE T; MITCHELL JD; KILSHAW J; PALL HS; GOODWIN M; SCHADY W; DUNCAN S; MOORE C; RICKARDS C; SHAW PJ; PICKERING CB; SWASH M; GOOCH CL; ECHOLS CW; QUIEN A; THORNELL B; ROTHSTEIN JD; CLAWSON L; SUFIT R; CASEY P
      CLINICAL-TRIALS OF RILUZOLE IN PATIENTS WITH ALS

      Neurology
    32. HERMANS E; OCTAVE JN; MALOTEAUX JM
      INTERACTION OF THE COOH-TERMINAL DOMAIN OF THE NEUROTENSIN RECEPTOR WITH A G-PROTEIN DOES NOT CONTROL THE PHOSPHOLIPASE-C ACTIVATION BUT ISINVOLVED IN THE AGONIST-INDUCED INTERNALIZATION

      Molecular pharmacology
    33. HERMANS E; MALOTEAUX JM
      DESENSITIZATION OF NEUROTENSIN-INDUCED PHOSPHOINOSITIDE HYDROLYSIS INTRANSFECTED CHO CELLS

      Biochemical pharmacology
    34. SAM E; JEANJEAN AP; MALOTEAUX JM; VERBEKE N
      APOMORPHINE PHARMACOKINETICS IN PARKINSONISM AFTER INTRANASAL AND SUBCUTANEOUS APPLICATION

      European journal of drug metabolism and pharmacokinetics
    35. JEANJEAN AP; MOUSSAOUI SM; MALOTEAUX JM; LADURON PM
      INTERLEUKIN-1-BETA INDUCES LONG-TERM INCREASE OF AXONALLY TRANSPORTEDOPIATE RECEPTORS AND SUBSTANCE-P

      Neuroscience
    36. HOLEMANS S; FERON O; OCTAVE JN; MALOTEAUX JM
      INTERACTION OF FLUORESCEIN DERIVATIVES WITH GLIBENCLAMIDE BINDING-SITES IN RAT-BRAIN

      Neuroscience letters
    37. HERMANS E; GAILLY P; GILLIS JM; OCTAVE JN; MALOTEAUX JM
      LACK OF RAPID DESENSITIZATION OF CA2-INDUCED INTERNALIZATION( RESPONSES IN TRANSFECTED CHO CELLS EXPRESSING THE RAT NEUROTENSIN RECEPTOR DESPITE AGONIST)

      Journal of neurochemistry
    38. MALOTEAUX JM; LUABEYA MK; VANISBERG MA; JEANJEAN AP; BAUDHUIN P; SCHERMAN D; LADURON PM
      SUBCELLULAR-DISTRIBUTION OF RECEPTOR-SITES IN HUMAN BRAIN - DIFFERENTIATION BETWEEN HEAVY AND LIGHT STRUCTURES OF HIGH AND LOW-DENSITY

      Brain research
    39. EMILIEN G; MALOTEAUX JM; SEGHERS A; CHARLES G
      LITHIUM-THERAPY IN THE TREATMENT OF MANIC-DEPRESSIVE ILLNESS - PRESENT STATUS AND FUTURE PERSPECTIVES - A CRITICAL-REVIEW

      Archives internationales de pharmacodynamie et de therapie
    40. LAMBERT DM; POUPAERT JH; MALOTEAUX JM; DUMONT P
      ANTICONVULSANT ACTIVITIES OF N-BENZYLOXYCARBONYLGLYCINE AFTER PARENTERAL ADMINISTRATION

      NeuroReport
    41. JEANJEAN AP; MALOTEAUX JM; LADURON PM
      IL-1-BETA-LIKE FREUNDS-ADJUVANT ENHANCES AXONAL-TRANSPORT OF OPIATE RECEPTORS IN SENSORY NEURONS

      Neuroscience letters
    42. LEVIVIER M; HOLEMANS S; TOGASAKI DM; MALOTEAUX JM; BROTCHI J; PRZEDBORSKI S
      QUANTITATIVE ASSESSMENT OF QUINOLINIC ACID-INDUCED STRIATAL TOXICITY IN RATS USING RADIOLIGAND BINDING ASSAYS

      Neurological research
    43. GAILLY P; HERMANS E; MALOTEAUX JM; OCTAVE JN; GILLIS JM
      NEUROTENSIN-INDUCED CALCIUM RESPONSE IN CHO CELLS EXPRESSING THE RAT NEUROTENSIN RECEPTOR - DEPLETION OF INTRACELLULAR STORES COUPLED TO CALCIUM-ENTRY

      Pflugers Archiv
    44. BENSIMON G; LACOMBLEZ L; MEININGER V; BOUCHE P; DELWAIDE C; COURATIER P; BLIN O; VIADER F; PEYROSTPAUL H; DAVID J; MALOTEAUX JM; HUGON J; LATERRE EC; RASCOL A; CLANET M; VALLAT JM; DUMAS A; SERRATRICE G; LECHEVALLIER B; PEUCH AJ; NGUYEN T; SHU C; BASTIEN P; PAPILLON C; DURRLEMAN S; LOUVEL E; GUILLET P; LEDOUX L; ORVOENFRIJA E; DIB M
      A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS

      The New England journal of medicine
    45. HOLEMANS S; JAVOYAGID F; AGID Y; DEPAERMENTIER F; LATERRE EC; MALOTEAUX JM
      SULFONYLUREA BINDING-SITES IN NORMAL HUMAN BRAIN AND IN PARKINSONS-DISEASE, PROGRESSIVE SUPRANUCLEAR PALSY AND HUNTINGTONS-DISEASE

      Brain research
    46. HERMANS E; GAILLY P; OCTAVE JN; MALOTEAUX JM; GILLIS JM
      CHARACTERIZATION OF THE AGONIST-INDUCED CALCIUM MOBILIZATION IN TRANSFECTED CHO CELLS EXPRESSING THE RAT NEUROTENSIN RECEPTOR

      Biophysical journal
    47. MALOTEAUX JM; HERMANS E
      AGONIST-INDUCED MUSCARINIC CHOLINERGIC RECEPTOR INTERNALIZATION, RECYCLING AND DEGRADATION IN CULTURED NEURONAL CELLS - CELLULAR MECHANISMSAND ROLE IN DESENSITIZATION

      Biochemical pharmacology
    48. HERMANS E; OCTAVE JN; MALOTEAUX JM
      RECEPTOR-MEDIATED INTERNALIZATION OF NEUROTENSIN IN TRANSFECTED CHINESE-HAMSTER OVARY CELLS

      Biochemical pharmacology
    49. HERMANS E; GAILLY P; OCTAVE JN; MALOTEAUX JM
      RAPID DESENSITIZATION OF AGONIST-INDUCED CALCIUM MOBILIZATION IN TRANSFECTED PC12 CELLS EXPRESSING THE RAT NEUROTENSIN RECEPTOR

      Biochemical and biophysical research communications
    50. HERMANS E; JEANJEAN AP; LADURON PM; OCTAVE JN; MALOTEAUX JM
      POSTNATAL ONTOGENY OF THE RAT-BRAIN NEUROTENSIN RECEPTOR MESSENGER-RNA

      Neuroscience letters
    51. NICOLI F; VIONDURY J; MALOTEAUX JM; DELWAIDE C; CONFORTGOUNY S; SCIAKY M; COZZONE PJ
      CSF AND SERUM METABOLIC PROFILE OF PATIENTS WITH HUNTINGTONS-CHOREA -A STUDY BY HIGH-RESOLUTION PROTON NMR-SPECTROSCOPY AND HPLC

      Neuroscience letters
    52. JEANJEAN AP; MESTRE M; MALOTEAUX JM; LADURON PM
      IS THE SIGMA(2) RECEPTOR IN RAT-BRAIN RELATED TO THE K-III ANTIARRHYTHMIC DRUGS( CHANNEL OF CLASS)

      European journal of pharmacology
    53. HOLEMANS S; DEPAERMENTIER F; HORTON RW; CROMPTON MR; KATONA CLE; MALOTEAUX JM
      NMDA GLUTAMATERGIC RECEPTORS, LABELED WITH [H-3] MK-801, IN BRAIN SAMPLES FROM DRUG-FREE DEPRESSED SUICIDES

      Brain research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 14:22:57